Cargando…
The upregulation of circFNDC3B aggravates the recurrence after endoscopic submucosal dissection (ESD) in early gastric cancer (EGC) patients
It has been reported that the expression of CD44 variant 9 could be utilized as a predictive marker for the recurrence in early gastric cancer (EGC) after endoscopic submucosal dissection (ESD). And circFNDC3B was proved to increase the migration and invasion of gastric cancer (GC) cells. In this st...
Autores principales: | Zhang, Jing, Bai, Jun, Zhu, Hongbing, Li, Wei, An, Qunxing, Wang, Dongxu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007947/ https://www.ncbi.nlm.nih.gov/pubmed/35418175 http://dx.doi.org/10.1038/s41598-022-07154-y |
Ejemplares similares
-
circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
por: Li, Xiang, et al.
Publicado: (2023) -
Emerging landscape of circFNDC3B and its role in human malignancies
por: Sun, Kai, et al.
Publicado: (2023) -
Expression of microRNA-328 Functions as a Biomarker for Recurrence of Early Gastric Cancer (EGC) After Endoscopic Submucosal Dissection (ESD) by Modulating CD44
por: Xue, Hui-guang, et al.
Publicado: (2016) -
Endoscopic Submucosal Dissection (ESD) in Colorectal Tumors
por: Dumoulin, Franz Ludwig, et al.
Publicado: (2014) -
Endoscopic Submucosal Dissection (ESD) Training and Performing ESD with Accurate and Safe Techniques
por: Kwon, Chang-Il
Publicado: (2012)